Skip to content
Methodology
All entries for: Dewpoint Therapeutics Inc.
October 22, 2025
Dewpoint Therapeutics Inc.
Orphan Drug Designation
FDA orphan drug designation: treatment of gastric cancer, including gastroesophageal junction cancer
Disease Area:
Rare Diseases
Source
Scroll to Top